Blessing Aghaulor, MD, MPH, a former resident in internal medicine and current fellow in Gastroenterology and Hepatology, has conducted research on transplant outcomes and consulted about patients at the ERASE trafficking clinic in Chicago.
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
A Northwestern Medicine study has found that women with hormone receptor-positive breast cancer were more likely to discontinue hormone therapy early due to poor quality of life-related outcomes.
Natalie Cameron, MD, a general internal medicine research fellow in the Department of Medicine, will be inducted into the Lewis Landsberg Society, which connects former residents and fellows from Northwestern University Feinberg School of Medicine.
Pregnant women who are diagnosed with COVID-19 have a higher risk of severe maternal morbidity and mortality and neonatal complications compared to pregnant women without COVID-19, according to recent findings.
A new wearable device developed at Northwestern measures mothers’ and babies’ vital signs and data that cannot be collected with current technology.
Three Feinberg students have received Harvard-BU-Northwestern-University of New Mexico Fogarty Global Health Fellowships, supporting work in Botswana, South Africa and Tanzania.
A new antibody drug demonstrated similar efficacy to currently available therapies to treat advanced ERBB2-positive breast cancer, according to a recent clinical trial.
Abbey Filicko, a third-year medical student, presented findings from her community-based participatory research project in partnership with Chicago Public Schools at this year’s American Public Health Association (APHA) virtual annual meeting.
A team led by Northwestern Medicine investigators has identified a novel molecular target that may improve the efficacy of current treatments for triple-negative breast cancer.